Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd): are Current Models Suitable to Evaluate Personalized Medicine. - Hoogendoorn, M; Feenstra, T; Asukai, Y; Briggs, A; Borg, S; dal Negro, R; Hansen, RN; Jansson, S; Wacker, M; Risebrough, N; Samyshkin, Y; Leidl, R; et al. (Value in Health, 2015)